A Report from SABCS Up-to-Date Review of the Treatment of Advanced Breast Cancer
Best of SABCS
7
February 2021 06:00pm - 09:00pm http://webinar365.in/hcmpl-sabcs/ Contact Us: PALAK AGARWAL (M)+91 99172 33854 HCMPL STREAMING PARTNER Licensed by Endorsed by Surgical Workshop Surgical Workshop 19th February, 2021 19th February, 2021 06:00PM - 09:00PM 06:00PM - 09:00PM Hall B Hall B Surgical Workshop 19th February, 2021 06:00PM - 09:00PM Hall B [email protected] www.bosindia.in
Transcript of Best of SABCS
-19 February 2021
06:00pm - 09:00pm
http://webinar365.in/hcmpl-sabcs/
Contact Us: PALAK AGARWAL
(M)+91 99172 33854
HCMPL
STREAMING PARTNER
Licensed byEndorsed by
Surgical Workshop Surgical Workshop 19th February, 202119th February, 202106:00PM - 09:00PM06:00PM - 09:00PM
Hall B Hall B
Surgical Workshop 19th February, 202106:00PM - 09:00PM
Hall B
[email protected] www.bosindia.in
[email protected] www.bosindia.in
Dr Purvi Thakkar�Mumbai
Dr Rohan Khandelwal�Delhi
Dr Megha Tandon�Delhi
Convenors
Dr. SVS Deo
Delhi
Program Director
Organizing Team
Dr. Meenu WaliaDirector
Department of Medical OncologyMax Super Speciality Hospital, Delhi
(M) +91 9818994001(E) [email protected]
Organizing Secretary
Dr. Vikas TalrejaConsultant,
Department of Medical OncologyRegency Hospital, Kanpur
(M) +91 9769890961(E) [email protected]
Co Organizing Secretary
Scientific Program
[email protected] www.bosindia.in
Day 1 || Friday, 19th February 2021 || 06:00pm-09:00pmHall B (Surgical Workshop)
Program Director: Dr. SVS Deo | Convenor: Dr. Purvi, Dr. Megha, Dr. Rohan
Session Coordinator Dr Megha Tandon
05:55pm - 06:00pm Welcome Note Dr. SVS Deo, Delhi
06:00pm - 06:05pm ES5 SABCS with the Society of Surgical Dr. Kanchan Kaur, Oncology present De-escalation of Surgical Therapy: Gurgaon What Does the Data Support
06:05pm - 06:10pm PS1-17 Comparing survival differences between Dr. Suhani, Delhi breast-conserving therapy and mastectomy in patients with early-stage breast cancer undergoing upfront surgery
06:10pm - 06:15pm SPD4-03 Can genomic profiling eliminate the Dr. Piyush Mishra, Delhi need for SLNB in ER positive, T1-2 breast cancer?
06:15pm - 06:20pm PS1-22 The oncological safety of lipofilling after Dr. Sadaf, UK breast cancer surgery: A meta-analysis
06:20pm - 06:25pm SPD4-01 Preservation of axillary lymph nodes Dr Purvi Thakkar, compared to complete dissection in T1-T2 breast Mumbai cancer patients presenting 1-2 metastatic sentinel lymph nodes : A multicenter randomized clinical trial. Sinodar One
06:25pm - 06:32pm Expert Comments Dr Gaurav Agarwal, Lucknow
Time Topic Speaker
[email protected] www.bosindia.in
Time Topic
Session Coordinator : Dr Purvi Thakkar
06:32pm - 06:37pm PS1-25 Axillary management after neoadjuvant Dr Megha Tandon, Delhi chemotherapy in initially node positive early breast cancer
06:37pm - 06:42pm SPD4-02 Sentinel node biopsy should not be Dr Rohan Khandelwal, routine in older patients with ER positive breast Gurgaon cancer
06:42pm - 06:47pm PS1-37 Reduction mammoplasty in the setting of Dr Neerja Gupta, Delhi neoadjuvant chemotherapy
06:47pm - 06:52pm SPD4-04 Tailored axillary surgery to omit axillary Dr Shilpi Dolas, Pune lymph node dissection independently from the use of neoadjuvant chemotherapy in patients with clinically node-positive breast cancer: Pre-specified subproject within TAXIS (SAKK 23/16 / IBCSG 57-18 / ABCSG-53 / GBG 101)
06:52pm - 06:57pm PS1-36 Outcomes and management of positive and Dr. Mihir Chanddaraa, close anterior margins following skin-sparing UK mastectomy
06:57pm - 07:05pm Expert Comments Dr Rosina Ahmed, Kolkata
Session Coordinator Dr Rohan Khandelwal
07:05pm - 07:10pm OT-04-01 Axillary management in T1-3N1M0 Dr Pragnya C, breast cancer patients with needle biopsy proven Hyderabad nodal metastases at presentation after neoadjuvant chemotherapy - ATNEC (ClinicalTrials.gov NCT04109079) 07:10pm - 07:15pm PS1-32 A multicentre prospective feasibility study Dr Deepak Jha, Gurgaon of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients
07:15pm - 07:20pm OT-04-02 The AXSANA trial (AXillary Surgery Dr Nisha Hariharan, After NeoAdjuvant treatment): An international Mumbai prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)
[email protected] www.bosindia.in
Time Topic
07:20pm - 07:25pm PS1-30 A prospective phase II trial to evaluate the Dr Neha Choudhary, feasibility of omit sentinel lymph node biopsy after Kolkata integrate18F-FDG dedicated axillary PET in early breast cancer: SOAPET trial
07:25pm - 07:30pm SPD4-05 Axillary recurrence is a rare event in Dr Pranjali Gadgil, Pune node-positive patients. treated with sentinel node biopsy alone after neoadjuvant chemotherapy: results of a prospective study
07:30pm - 07:37pm Expert Comments Dr Diptendra Sarkar, Kolkata
Session Coordinator Dr Megha Tandon
07:37pm - 07:42pm SPD4-06 How often does retrieval of a clipped Dr Vaishali Zamre, lymph node change adjuvant therapy Ghaziabad recommendations? A prospective consecutive patient cohort
07:42pm - 07:47pm PS1-51 A nomogram for predicting three or more Dr Asha Reddy, Chennai axillary lymph node involvement before breast cancer surgery
07:47pm - 07:52pm SPD4-08 Does genomic recurrence score predict Dr Garvit Chitkara, for ipsilateral breast tumor recurrence after breast Mumbai conservation therapy?
07:52pm - 07:57pm PS1-55 Clipping of involved axillary lymph nodes Dr Karishma Kirti, before neo adjuvant chemotherapy may improve in Mumbai identification rates & staging of axilla in breast cancer
07:57pm - 08:02pm SPD7-01 Towards personalized medicine - Dr Aditi Chaturvedi, Patient-derived breast tumor grafts as predictors of Delhi relapse and response to therapy. Preliminary results
08:02pm - 08:06pm PS1-50 Locoregional therapy in de novo metastatic Dr Chitresh K Sharma breast cancer: Systemic review and meta-analysis
08:06pm - 08:14pm Expert Comments Dr. Nita Nair, Mumbai
[email protected] www.bosindia.in
Time Topic
Session Coordinator Dr Purvi Thakkar
08:15pm - 08:40pm Panel Discussion:
Moderator Dr Vedant Kabra, Delhi
Panelists Dr. Nita Nair, Mumbai Dr Gaurav Agarwal,Lucknow Dr Rosina Ahmed, Kolkata Dr Diptendra Sarkar, Kolkata Dr. Mandeep Singh Dr Shalaka Joshi, Mumbai Dr. Arun Goel, Delhi
Expert Comments Dr. Ramesh Sarin, Delhi
Session Coordinator Dr Rohan Khandelwal
08:40pm - 09:00pm Debate: De-escalation of Surgical Therapy: What Does the Data Support DCIS
Pro Dr S P Somashekhar, Bengaluru
Cons Dr Geeta K, New Delhi
Expert Comments Dr Uttam Soni, Jaipur
09:00pm - 09:10pm Surgical Management in Breast Cancer 2021 & Dr Harit Chaturvedi, Beyond Delhi
09:10pm Onwards Vote of Thanks
HCMPL
STREAMING PARTNER
Contact Us: PALAK AGARWAL
(M)+91 99172 33854
Connect us on:www.hcmpl.com
http://webinar365.in/hcmpl-sabcs/
Scientific Partners
ONCOLOGY
[email protected] www.bosindia.in
![[PPT]HER Education Network · Web viewA Report from SABCS Up-to-Date Review of the Treatment of Early Breast Cancer Maura N. Dickler, MD Assistant Attending Physician Breast Cancer](https://static.fdocuments.in/doc/165x107/5ad30c367f8b9a05208d6de6/ppther-education-viewa-report-from-sabcs-up-to-date-review-of-the-treatment-of.jpg)
